During the last months of the coronavirus pandemic, with all those public restrictions and health interventions, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appears now to have been raised in some countries around the world. Iran was one of those first countries facing the second wave of coronavirus, due to the lack of appropriate public restrictions because of economic problems the country is facing. The clinical and demographic characteristics of severe cases and non-severe cases of Coronavirus Disease (COVID-19) in 192 patients in Tehran, Iran, between June 16 and July 11, 2020, were investigated. The patients were divided into severe cases (n = 82) and non-severe cases (n = 110). Demographic and clinical characteristics were compared between the two study clusters. The mean age was 54.6 ± 17.2 years, and the most common presenting symptom was persistent cough (81.8%) and fever (79.7%). The logistic regression model revealed that age, BMI, and affected family members were statistically associated with severity. Patients with complicated conditions of disorders faced more hospitalization days and medical care than the average statistical data. As the coronavirus spike in the case and death reports from June 2020, we observed the rise in the incidence of severe cases, where 42.7% (82/192) of cases have resulted in severe conditions. Our findings also suggested that the effect of IFB (Betamethasone) was more valid than the other alternative drugs such as LPV/r and IVIg.
Citrulline antibody, nowadays, is a new item which has been the center of attention due to its much more specificity to diagnose RA. The aim of the present study was to evaluate the efficacy and accuracy of anti-citrulline antibody test in RA diagnosis among hospitalized patients in Iran. Through a case-control study, we tried to calculate the accuracy of anti-cyclic citrullinated peptide antibody (anti-CCP) test used in the diagnosis of RA enrolling 200 participants divided into two groups of the patients with RA, on the one hand, and other diseases, on the other. Anti-CCP was measured by ELISA technique through which titers more than 15 were defined as high titer. Of all the studied population, 81 (81 %) were in active phase of RA, which had anti-CCP >15 U/ml, while only 25 controls (25 %) experienced these levels. The average anti-CCP was 144 U/ml in cases and 16.05 U/ml in controls with a P value <0.001, which confirmed significant difference between the two. Considering different comments on this matter besides our findings in the present research, we offer a combination of anti-citrulline antibody test rather than anti-CCP and RF to get the best results in RA diagnosis, discrimination and prognosis because of 97 % specificity.
Background: Osteoarthritis (OA) is one of the most common chronic rheumatoid diseases, which affects the cartilage and tissue surrounding the joints. OA causes pain and disability among the old population in most of the developing and developed countries. This disease does not have a definitive treatment, and a conventional treatment only controls the symptoms and pain. Pistacia atlantica cream can inhibit many of the enzymes involved in the inflammation process of OA. Objectives: The current study aimed at evaluating the effect of the topical cream of P. atlantica oleoresin on pain relief in patients with knee OA. Methods: P. atlantica cream formulated in the current study was used to reduce the pain, inflammation, and problems of patients with knee OA; it also descended the serious side effects of conventional therapies. The present clinical trial was conducted on 84 patients with knee OA (grade 2 or 3) parallelly for three-month periods, and diclofenac gel was used as a control drug in the same dosage and period. The formulation was analyzed for standardization with the gas chromatography–mass spectrometry apparatus. The Western Ontario and McMaster universities OA index questionnaire was used to assess the treatment trends. Results: The improvement trend was observed in both groups, while patients who received P. atlantica cream had a significantly higher rate of symptoms improvement than those receiving diclofenac gel (P < 0.05). Conclusions: P. atlantica cream significantly reduced pain and stiffness of joints in patients while performing daily living activities. High analgesic effect of α-pinene and the anti-inflammatory effect of P. alantica were the main reasons for the high inflammatory effect of P. atlantica. Finally, the topical use of P. atlantica cream formulated in the current study, along with other common drugs, can be suggested.
Introduction: The recent pandemic of the SARS-CoV-2 virus has significantly increased the mortality and disability burden in many people worldwide. Several effective vaccines have been introduced since the outbreak of the coronavirus. These vaccines work through several different immunization pathways to create effective immunity. In this respect, there have been no reports of patients with symptoms of lumbar radiculopathy and puffiness of the hands after receiving corona vaccines. This article presents a clinical case report of these symptoms after receiving the MRNA12-73 (Moderna) vaccine. Overall, finding effective, low-complication, and safe solutions against this virus can have a beneficial effect in reducing the side effects of the Corona vaccine and maintaining the health and lives of people. Case history: A 73-year-old male patient developed lumbar radiculopathy and puffy hands after receiving the corona (COVID-19) vaccine. He was infected with COVID-19 about 60 days after receiving the MRNA12-73 (Moderna) vaccine. Conclusion: Attention to the occurrence of any side effects after injecting corona vaccines requires additional studies. It is also important to follow up on any clinical signs of suspected coronary involvement, even after the vaccination.
Background: Tennis elbow (TE), as a lateral epicondylitis (LE), is a chronic inflammatory and degenerative tendon disease that causes pain in the outer part of the elbow. This study aimed to evaluate the efficacy of topical Trinitrate Glyceryl (GTN) in the treatment of patients with TE. Materials and methods: In this double-blind clinical trial, 90 patients with TE, referred to Orthopedic and Rheumatology Clinics of Bou-Ali Hospital in Tehran from October 2012 until January 2014, have been studied. They were randomly divided into 2 groups of 45 subjects (treatment and control group). Intervention group received dermal patches and GTN-containing drop, and the control group received dermal patches and liquid paraffin-containing drop (placebo). Results: Significant improvement in pain and tenderness was observed after 2, 4 and 6 weeks in intervention group compared to control group (p<0.05). Conclusion:Based on the findings of this study, GTN has a significant effect on pain relief and tenderness in patients with TE.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.